“Patents tend to hinder research and technological development instead of helping them. So as a basic researcher, I want nothing to do with patents."
This is an interesting topic. Even today, experts still debate whether patents really always promote progress and innovation, as illustrated by many disputes in individual cases (see FAQs: What benefits do industrial property rights have for society? )
Nevertheless, problems in individual cases do not necessarily mean that the regulations generally are flawed. Patents are usually what make it possible to successfully transfer research results into practice. And if, hypothetically, universities did not take advantage of their opportunities with patents, they would ultimately only be squandering valuable revenue opportunities for their own research and development. In the US alone, small biotech companies and universities contributed 56 percent of all truly innovative new active ingredients in pharmaceutical research between 1998 and 2007 (Nature Rev. Drug Discov. 9, 867ff (2010)).
Only through their own patents can universities profit from their inventions and thus ultimately recoup part of the government's research expenditure via commercial revenues. In this country, the law (Arbeitnehmererfindungsgesetz) has given them the opportunity to do so since 2002.
In the USA, the Bayh Dole Act granted state-funded research institutes the right to commercialize research results as early as 1980. Currently, the proportion of basic research in universities has by no means declined, but has rather been boosted by the incentive of commercial exploitation. (details here.)